Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/6/2026

1. HUBS
2. KVYO
3. DOX
4. DASH
5. WDC
6. ZG
7. PAYC
8. APP
9. SNDK
10. XYZ

Go back to Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
Pfizer Inc. (NYSE: PFE) Delayed: 25.81 --0 (-0%)
Previous Close $25.81    52 Week High $37.39 
Open $25.81    52 Week Low $28.25 
Day High $25.81    P/E 15.64 
Day Low $25.81    EPS $1.65 
Volume 200,415